.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Covington
Novartis
Deloitte
Chubb
Farmers Insurance
Dow
Chinese Patent Office
Accenture

Generated: November 24, 2017

DrugPatentWatch Database Preview

ROBAXIN Drug Profile

« Back to Dashboard

Which patents cover Robaxin, and what generic Robaxin alternatives are available?

Robaxin is a drug marketed by Auxilium Pharms Llc and West-ward Pharms Int and is included in two NDAs.

The generic ingredient in ROBAXIN is methocarbamol. There are twenty-seven drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the methocarbamol profile page.

Pharmacology for ROBAXIN

Medical Subject Heading (MeSH) Categories for ROBAXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Auxilium Pharms Llc
ROBAXIN
methocarbamol
TABLET;ORAL011011-004Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
ROBAXIN
methocarbamol
SOLUTION;IM-IV011790-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Auxilium Pharms Llc
ROBAXIN-750
methocarbamol
TABLET;ORAL011011-006Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
US Department of Justice
Harvard Business School
QuintilesIMS
Fish and Richardson
McKinsey
Teva
Covington
Queensland Health
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot